2024-11-22 06:15:58
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031
Health/ 2023-09-26
Antengene Announces Phase I Study of Ant...

- The Phase I"PERFORM" studywill evaluate the safety and tolerability,pharmacology,immunogenicity,and preliminary efficacy of ATG-...

New Wacom Signature Displays expand digital signature capture options for healthcare, financial services and transaction management
Health/ 2023-09-26
New Wacom Signature Displays expand digi...

HONG KONG,Sept. 21,2023-- Wacom announces its new Signature Displays the 13 touch (DTH134) and 12 (DTC121),a new eDocument solution enabling...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release